485 related articles for article (PubMed ID: 28242339)
1. Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.
Goodwani S; Saternos H; Alasmari F; Sari Y
Neurosci Biobehav Rev; 2017 Jun; 77():14-31. PubMed ID: 28242339
[TBL] [Abstract][Full Text] [Related]
2. Glutamatergic targets for new alcohol medications.
Holmes A; Spanagel R; Krystal JH
Psychopharmacology (Berl); 2013 Oct; 229(3):539-54. PubMed ID: 23995381
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.
Reiner A; Levitz J
Neuron; 2018 Jun; 98(6):1080-1098. PubMed ID: 29953871
[TBL] [Abstract][Full Text] [Related]
4. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
5. Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.
Sobrio F
J Labelled Comp Radiopharm; 2013; 56(3-4):180-6. PubMed ID: 24285324
[TBL] [Abstract][Full Text] [Related]
6. Activation of NMDA receptors reduces metabotropic glutamate receptor-induced long-term depression in the nucleus accumbens via a CaMKII-dependent mechanism.
Huang CC; Hsu KS
Neuropharmacology; 2012 Dec; 63(8):1298-307. PubMed ID: 22947307
[TBL] [Abstract][Full Text] [Related]
7. Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.
Reiner A; Levitz J; Isacoff EY
Curr Opin Pharmacol; 2015 Feb; 20():135-43. PubMed ID: 25573450
[TBL] [Abstract][Full Text] [Related]
8. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Lange F; Hörnschemeyer J; Kirschstein T
Cells; 2021 May; 10(5):. PubMed ID: 34067762
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of metabotropic and ionotropic glutamate striatal receptors blockade influence on rats locomotor behaviour].
Iakimovskiĭ AF; Kerko TV
Ross Fiziol Zh Im I M Sechenova; 2013 Feb; 99(2):221-9. PubMed ID: 23650735
[TBL] [Abstract][Full Text] [Related]
10. The function of metabotropic glutamate receptors in thalamus and cortex.
Sherman SM
Neuroscientist; 2014 Apr; 20(2):136-49. PubMed ID: 23459618
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens.
Martin G; Nie Z; Siggins GR
J Neurophysiol; 1997 Dec; 78(6):3028-38. PubMed ID: 9405522
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic control of a pattern-generating central nucleus in a gymnotiform fish.
Comas V; Borde M
J Neurophysiol; 2021 Jun; 125(6):2339-2355. PubMed ID: 33978492
[TBL] [Abstract][Full Text] [Related]
13. Glutamate receptor agonists: stereochemical aspects.
Vogensen SB; Greenwood JR; Bunch L; Clausen RP
Curr Top Med Chem; 2011; 11(7):887-906. PubMed ID: 21291400
[TBL] [Abstract][Full Text] [Related]
14. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Koltunowska D; Gibula-Bruzda E; Kotlinska JH
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
[TBL] [Abstract][Full Text] [Related]
15. Activation of NOX2 by the stimulation of ionotropic and metabotropic glutamate receptors contributes to glutamate neurotoxicity in vivo through the production of reactive oxygen species and calpain activation.
Guemez-Gamboa A; Estrada-Sánchez AM; Montiel T; Páramo B; Massieu L; Morán J
J Neuropathol Exp Neurol; 2011 Nov; 70(11):1020-35. PubMed ID: 22002428
[TBL] [Abstract][Full Text] [Related]
16. Mood disorders: regulation by metabotropic glutamate receptors.
Pilc A; Chaki S; Nowak G; Witkin JM
Biochem Pharmacol; 2008 Mar; 75(5):997-1006. PubMed ID: 18164691
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
Alexander GM; Godwin DW
Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
Maranis S; Stamatis D; Tsironis C; Konitsiotis S
Eur J Pharmacol; 2012 May; 683(1-3):71-7. PubMed ID: 22410193
[TBL] [Abstract][Full Text] [Related]
19. Structural biology of ionotropic glutamate delta receptors and their crosstalk with metabotropic glutamate receptors.
Burada AP; Vinnakota R; Lambolez B; Tricoire L; Kumar J
Neuropharmacology; 2021 Sep; 196():108683. PubMed ID: 34181979
[TBL] [Abstract][Full Text] [Related]
20. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
